| Time (UTC+8) | Topic | Speaker | Moderator | Abstract | Slides | Video | |
|---|---|---|---|---|---|---|---|
| 08:30 - 09:00 | Registration & Opening |
Shou-Tung Chen
|
Video | ||||
| 09:00 - 09:30 | Global International-Initiated Trial (PATHWAY Trial) in Asian Countries for HR-Positive/HER2-Negative Advanced Breast Cancer |
Kenji Tamura
|
King-Jen Chang
|
Video | |||
| 09:30 - 10:00 | Are All Triple Negative Breast Cancers the Same? |
Jorge S. Reis-Filho
|
Cheng-Ping Yu
|
Video | |||
| 10:00 - 10:30 | Current Status and Future Prospects of Immunotherapy in Breast Cancer Treatment: Past, Present, and Future |
Tan Jing Ying Tira
|
Ching-Hung Lin
|
Video | |||
| 10:30 - 10:50 | Coffee Break | ||||||
| 10:30 - 10:50 | Screening, Diagnosis and Surveillance Between East and West |
Eun Sook Ko
|
|||||
| 10:50 - 11:10 | Difference in Surgical Considerations and Oncoplastic Surgery Between East and West |
Wen-Ling Kuo
|
|||||
| 10:50 - 11:20 | Precision Immunotherapy for TNBC: From Clinical Factors to Tumor Microenvironment |
Giampaolo Bianchini
Hsien-Kun Chang
|
Ming-Feng Hou
|
Video | |||
| 10:50 - 11:00 | [B006] Collagen family proteins, thrombospondin 1 and lumican are differentially expressed across breast cancer subtypes by functional proteomics: a preliminary study with bioinformatics analysis |
Chi-Cheng Huang
|
|||||
| 11:00 - 11:10 | [B003] Integrative Omics Analysis Reveals DTX1 as a Key Marker and Drug Target in Breast Cancer |
Yen-Dun Tzeng
|
|||||
| 11:10 - 11:30 | Difference in Medical Considerations and Survivorship Between East and West |
Hyun Jo Youn
|
|||||
| 11:10 - 11:20 | [B009] Therapeutic Co-Targeting of the BTK/HER2 Axis Induces Iron Accumulation to Overcome Trastuzumab Resistance in HER2-Positive Breast Cancer |
Chih-Ming Su
|
|||||
| 11:20 - 11:50 | From Consistent 1L CDK4/6i Evidence-Based Survival Benefit to Real-World Clinical Practice in HR+HER2- mBC |
Shih-Yu Huang
|
Kuo-Ting Lee
|
Video | |||
| 11:20 - 11:30 | [B004] ATP synthasome contributes to efficient energy flux in malignant breast cancer |
Chia-Jung Li
|
|||||
| 11:30 - 12:00 | Panel Discussion:What Are the Unique Surgical Needs in Asian Population and How to Meet Them? |
Eun Sook Ko
Wen-Ling Kuo
Hyun Jo Youn
Chih-Chiang Hung
|
Hee Jeong Kim
Ming-Yang Wang
|
||||
| 11:30 - 11:40 | [B016] The application of a PI3K inhibitor and an AKT inhibitor in HER2-positive breast cancer cells with resistance to HER2-directed antibody-drug conjugates |
Wei-Pang Chung
|
|||||
| 11:40 - 11:50 | [B013] Targeting the USP7-CDK1 axis suppresses estrogen receptor-positive breast cancer progression |
Joseph Lin
|
|||||
| 11:50 - 12:10 | Panel Discussion |
Giampaolo Bianchini
Jorge S. Reis-Filho
Tan Jing Ying Tira
|
Takashi Ishikawa
Ming-Feng Hou
|
Video | |||
| 11:50 - 12:00 | [B015] SLC6A14-Mediated Glutamine Metabolism Reprogramming Enhances Cancer Stemness for Early Onset of Breast Cancer |
Meng-Xia Su
|
|||||
| 12:00 - 12:10 | [B001] Discovery and Biological Evaluation of a Novel Inhibitor for Human Breast Cancer Treatment |
Cheng-Chiao Huang
|
|||||
| 12:10 - 12:50 | Docetaxel, Aging Like a Fine Wine |
Chun-Yu Liu
|
Liang-Chih Liu
|
Video | |||
| 12:10 - 12:20 | [C025] Enhancing the Detection of Contralateral Breast Cancer in Breast Cancer Survivors Using Artificial Intelligence |
Jijung Jung
|
|||||
| 12:20 - 12:30 | [C013] Pattern of failure and timing of progression on CDK4/6 inhibitor as first line therapy for HR+HER2- metastatic breast cancer invading different organ |
Ruoh-Yun Kao
|
|||||
| 12:50 - 13:10 | Coffee Break | ||||||
| 13:00 - 13:05 | Young Doctors Forum/Debate Opening |
Chi-Cheng Huang
|
|||||
| 13:05 - 13:30 | [YDF] How to ask translational questions? |
Shiuan Chen
|
Hsu-Huan Chou
|
||||
| 13:10 - 13:40 | The Sustainable Efficacy of CDK4/6 Inhibitor Therapy in HR+/Her2- Node+ High Risk Early Breast Cancer |
Nadia Harbeck
|
Dar-Ren Chen
|
Video | |||
| 13:10 - 13:20 | [B010] Prognostic effects of ABCB1 and TMEM14B expression in triple-negative breast cancer |
Sin-Hua Moi
|
|||||
| 13:20 - 13:30 | [B025] Co-targeting PD-L1 and CDK4 benefits plasticizer-associated early-onset breast cancer |
Shu-Wei Hu
|
|||||
| 13:30 - 13:55 | [YDF] Agonies of Young Doctors within the South Korean Health Care System |
Jun Won Min
|
Hsu-Huan Chou
|
||||
| 13:30 - 13:40 | [B024] Mechanistic Insights into Melittin’s Efficacy Against Tamoxifen-Resistant Breast Cancer: Apoptosis, Proliferation, and Migration Modulation |
Min-Hua Wu
|
|||||
| 13:40 - 14:10 | Adjuvant Treatment for Young Age ER+ Early Breast Cancer (EBC) |
Prudence Francis
|
Shyr-Ming Sheen-Chen
|
Video | |||
| 13:40 - 13:50 | [B005] LOC100506691, a long noncoding RNA, acts as novel oncogene in regulating breast cancer growth |
Kian-Hwee Chong
|
|||||
| 13:50 - 14:00 | [B014] Molecular characterization of HER2 low breast cancers reveals a biologically and clinically distinct entity with heterozygous loss of ERBB2 |
Xintao Qiu
|
|||||
| 13:55 - 14:00 | [YDF] Q&A |
Hsu-Huan Chou
|
|||||
| 14:00 - 14:10 | [C016] Using Bilateral Thoracoabdominal Flaps for Extensive Defects After Bilateral Mastectomy for Inflammatory Breast Cancer |
Ryohei Katsuragi
|
|||||
| 14:00 - 14:40 | [YDD Topic 1] Should ALND Be Performed in ypN1micro Luminal Breast Cancer Patient with Initial cN1 After Neoadjuvant Chemotherapy? |
Yen-Jen Chen
Bo-Fang Chen
Hsu-Huan Chou
Chia-Hui Chu
An-Chieh Feng
Joan Gan Cheau Yan
Chih-Hao Huang
Sae Byul Lee
Sue Zann Lim
Zhu-Jun Loh
Hitomi Mori
Minjin Ulaankhuu
Youri Park
Yokoe Takamichi
Tan Ying Ching
Kaori Tane
Azzaya Terbish
|
Wen-Ling Kuo
|
||||
| 14:10 - 14:20 | [C061] Case Report of Stereotactic Body Radiation Therapy for Oligometastatic Breast Cancer Patient |
Masahiro Yoshida
|
|||||
| 14:10 - 14:40 | Bridging Treatment Gaps for Stage II and III HR+/HER2- Early Breast Cancer with CDK4/6 Inhibitors |
Stephen Chia
|
Fang-Ming Chen
|
Video | |||
| 14:20 - 14:30 | [B023] exoLinc-p21s: a short lincRNA-p21-engineered exosome as a chemosensitizer for targeting DDB2-mediated DNA repair |
Yu-Hao He
|
|||||
| 14:30 - 14:40 | [C009] LXPB5268 combined with neoadjuvant chemotherapy in early-stage Triple-Negative Breast Cancer patients |
Chin-Yin Kuo
|
|||||
| 14:40 - 15:00 | Coffee Break | ||||||
| 14:40 - 15:20 | [YDD Topic 2] Should Adjuvant Pembrolizumab Be Considered in Early TNBC Patients Achieving pCR After Neoadjuvant Chemotherapy Combined with Immunotherapy? |
Cheng-Wei Chou
Jeffrey Hing Jun Xian
Shih-Yu Huang
Po-Hsiang Huang
Ji-Jung Jung
Ki Jo Kim
Cho Eun Lee
Young-Jin Lee
Soo-Young Lee
Young-Won Lee
Chia-Chen Li
Joseph Lin
Kawon Oh
Meng-Ting Peng
Hidenobu Takahashi
I-Chen Tsai
Ming-Han Yang
|
Chun-Yu Liu
|
||||
| 15:00 - 15:10 | [C037] Multi-omics and spatial transcriptomics unveil the role of ferroptosis suppressor FANCD2 in clinicopathology and predicting immunotherapy response in breast cancer |
Hung-Yu Lin
|
|||||
| 15:00 - 15:30 | Long-Term Survival Benefits of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer: Insights from Real-World Evidence |
Hope S. Rugo
|
Fiona Tsui-Fen Cheng
|
Video | |||
| 15:10 - 15:20 | [C074] Combination of endocrine therapy, gonadotropin-releasing hormone agonist, and immunotherapy enhance immune activation in premenopausal ER+/HER2- metastatic breast cancer patients: final updates from PEER study |
I-Chun Chen
|
|||||
| 15:20 - 15:30 | [C030] Circulating CD3+CD8+ T lymphocytes as indicators of disease status in patients with early breast cancer |
Hui-Ping Hsu
|
|||||
| 15:20 - 15:30 | [YDD] Q&A Closing |
Jeong Eon Lee
|
|||||
| 15:30 - 16:00 | Novel Strategies to Overcome Resistance to Endocrine Therapy in HR+ aBC: From Biological Perspectives to Clinical Advances |
Javier Cortés
|
Tsu-Yi Chao
|
Video | |||
| 16:00 - 16:20 | Panel Discussion |
Javier Cortés
Prudence Francis
Hope S. Rugo
|
Shinji Ohno
Shin-Cheh Chen
|
Video | |||
| 16:20 - 16:50 | Navigating ADC to Clinical Success With the Learning from Current Research |
Leif Ellisen
|
Chiun-Sheng Huang
|
Video | |||
| 16:50 - 17:20 | Riding the Wave of Innovation: The evolving landscape of ADCs in Breast Cancer Treatment |
Paolo Tarantino
|
Jiun-I Lai
|
Video | |||
| 17:20 - 17:50 | Optimizing Survival: Individualized Adjuvant Strategies for Maximizing Neoadjuvant Benefits |
Sibylle Loibl
|
Ling-Ming Tseng
|
Video | |||
| 17:50 - 18:10 | Panel Discussion |
Leif Ellisen
Sibylle Loibl
Paolo Tarantino
|
Yen-Shen Lu
|
Video |
| Time (UTC+8) | Topic | Speaker | Moderator | Abstract | Slides | Video | |
|---|---|---|---|---|---|---|---|
| 08:20 - 08:50 | The Current Role of Combination Chemotherapy in Metastatic Breast Cancer Treatment |
Ta-Chung Chao
|
Nei-Min Chu
|
Video | |||
| 08:50 - 09:20 | Axillary Surgery in Clinically Node Negative and Positive Disease: Current Indication |
Jai Min Ryu
|
Yao-Jen Chang
|
Video | |||
| 09:20 - 10:00 | Current Topics in Breast Cancer Radiation Oncology: Axillary Management, Multi-Centric Disease, and Second Breast-Conserving Therapy |
Philip Poortmans
|
Jyh-Cherng Yu
|
Video | |||
| 10:00 - 10:30 | How to Avoid Axillary Dissection in Breast Cancer Patients with Metastatic Axillary Lymph Nodes on Preoperative Ultrasound? |
Jana de Boniface
|
Wen-Hung Kuo
|
Video | |||
| 10:30 - 10:50 | Panel Discussion |
Jana de Boniface
Philip Poortmans
|
Wonshik Han
Guo-Shiou Liao
|
Video | |||
| 10:50 - 11:10 | Coffee Break | ||||||
| 11:10 - 11:40 | Breast Cancer Biology for Precision Medicine |
Christos Sotiriou
|
Wen-Ling Kuo
|
Video | |||
| 11:40 - 12:10 | Diagnostic and Therapeutic Considerations in Tumor Microenvironments |
Mark Pegram
|
Chi-Cheng Huang
|
Video | |||
| 12:10 - 12:50 | Real World Evidence: Astragalus polysaccharides Injection and Breast Cancer Patients with Cancer-related Fatigue |
Ming-Shen Dai
|
Kun-Ming Rau
|
Video | |||
| 13:10 - 13:40 | Unmet Needs in Early-Stage HER2-Positive Breast Cancer: The Benefit of Extended Adjuvant Treatment |
Hsu-Huan Chou
|
Shih-Che Shen
|
Video | |||
| 13:40 - 14:10 | Cardio-Oncology: Protecting the Heart as Curative Breast Cancer Treatment |
Wei-Ting Chang
|
Hsien-Tang Yeh
|
Video | |||
| 14:10 - 14:40 | Navigating the Intersection of Breast cancer and Bone Health: the Role of Denosumab in Preventing Skeletal-Related Events |
Li-Kun Ko
|
Chin-Yao Lin
|
Video | |||
| 14:40 - 15:00 | Coffee Break | ||||||
| 15:00 - 15:30 | Potential Role of TIL Assessment in Clinical Practice |
Sherene Loi
|
Chen-Hsiang Chang
|
Video | |||
| 15:30 - 15:40 | What Should We Do on Monday Morning:TNBC? |
Yuan-Ching Chang
|
Shou-Tung Chen
|
Video | |||
| 15:40 - 15:50 | What Should We Do on Monday Morning:ER+? |
Dwan-Ying Chang
|
Shou-Tung Chen
|
Video | |||
| 15:50 - 16:40 | What Should We Do on Monday Morning: HER2+? |
Wei-Pang Chung
|
Shou-Tung Chen
|
Video | |||
| 16:00 - 16:20 | Award Ceremony & Closing |
Shou-Tung Chen
|